Transcriptomic and clinical data analyses from multiple cohorts of patients with cancer receiving immunotherapy find that PD-1 blockade potentiates tumor-specific IgG1 plasma cell responses that complement cellular immunity and contribute to clinical benefit.
- Edgar Gonzalez-Kozlova
- Robert Sweeney
- Sacha Gnjatic